Camp4 Therapeutics CAMP
NASDAQ CAMP
$3.29 +0.13 (+4.11%)
At close: Oct 21, 2026 · 4:00 PM EDT

Camp4 Therapeutics (CAMP) Preferred Stock Liabilities (2023 - 2024)

Updated

Camp4 Therapeutics (CAMP) recorded Preferred Stock Liabilities of $162.15 million in Q3 2024, unchanged from $162.15 million a year earlier and unchanged from the prior quarter.

Analysis

Camp4 Therapeutics (CAMP) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Starting with Q3 2023, Camp4 Therapeutics' Preferred Stock Liabilities history includes 5 quarters.

  • Per Business Quant, the preceding three quarters came in at $162.15 million (Q2 2024), $162.15 million (Q1 2024) and $162.15 million (Q4 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Camp4 Therapeutics 191.17 Mn -179.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 162.15 Mn
Jun 30, 2024 162.15 Mn
Mar 31, 2024 162.15 Mn
Dec 31, 2023 162.15 Mn
Sep 30, 2023 162.15 Mn
API Access

Camp4 Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CAMP&period=max&api_key=YOUR_API_KEY